非麻醉医师使用靶控输注丙泊酚在常规消化内镜中的安全性与耐受性结局
该回顾性队列研究纳入2019年5月至2021年11月在意大利米兰IRCCS San Raffaele医院连续招募的18,302例低风险(ASA I-II级)门诊消化内镜操作,评估非麻醉医师使用靶控输注丙泊酚的不良事件发生率与患者满意度。结果显示不良事件发生率为1.3%,胃镜与结肠镜间无差异(1.4% vs 1.2%,P=0.418),98.9%患者表示愿意重复相同镇静方案,年龄是唯一独立相关因素(OR 1.02)。作者认为该镇静方法有效且安全。
要点
- 18,302例低风险门诊内镜中,非麻醉医师靶控输注丙泊酚不良事件发生率为1.3%。
- 胃镜与结肠镜不良事件发生率无显著差异(1.4% vs 1.2%,P=0.418)。
- 98.9%患者表示愿意重复相同镇静方案,年龄是总体不良事件的唯一独立相关因素(OR 1.02)。
核心结论
- 非麻醉医师使用靶控输注丙泊酚是常规内镜的有效且安全的镇静方法。
- 根据患者个体情况给予适当丙泊酚剂量以及配备 trained operators 对非麻醉医师丙泊酚镇静管理至关重要。
研究设计与样本
- 回顾性队列研究,连续纳入2019年5月至2021年11月于意大利米兰IRCCS San Raffaele医院接受门诊消化内镜操作的低风险患者(美国麻醉医师协会评分I和II级),共18,302例操作。
主要发现
- 共分析7162例胃镜和11,140例结肠镜数据。
- 患者平均年龄59.1 ± 14.8岁,平均体重指数24.9 ± 3.7 kg/m2,男女比例为8798例(48.1%)比9486例(51.9%)。
- 总体队列中240例操作发生不良事件(1.3%),胃镜与结肠镜之间无差异(分别为100例[1.4%]和140例[1.2%],P = .418)。
- 大多数患者(15,875例[98.9%])表示愿意重复相同镇静方案的操作。
- 年龄是唯一与总体不良事件独立相关的因素(比值比1.02;95%置信区间1.01-1.03;P < .008)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Nonanesthesiologist-administered propofol (NAAP) is increasingly accepted, but data are limited on drug administration using target-controlled infusion (TCI) in clinical practice. TCI adjusts the drug infusion based on patient-specific parameters, maintaining a constant drug dose to reduce the risk of adverse events (AEs) because of drug overdosing and to enhance patient comfort. The aims of this study were to assess the rate of AEs and to evaluate patient satisfaction with NAAP using TCI in a retrospective cohort of 18,302 procedures. METHODS: Low-risk patients (American Society of Anesthesiologists score I and II) undergoing outpatient GI endoscopic procedures, including EGDs and colonoscopies, were sequentially enrolled at IRCCS San Raffaele Hospital (Milan, Italy) between May 2019 and November 2021. RESULTS: Data from 7162 EGDs and 11,140 colonoscopies were analyzed. Mean patient age was 59.1 ± 14.8 years, and mean body mass index was 24.9 ± 3.7 kg/m2. The male-to-female ratio was equal at 8798 (48.1%):9486 (51.9%). AEs occurred in 240 procedures (1.3%) out of the total cohort, with no differences between EGDs and colonoscopies (100 [1.4%] and 140 [1.2%], respectively; P = .418). Most patients (15,875 [98.9%]) indicated they would likely repeat the procedure with the same sedation protocol. Age (odds ratio, 1.02; 95% confidence interval, 1.01-1.03; P < .008) was the only independent factor associated with overall AEs. CONCLUSIONS: NAAP using TCI is an effective and safe sedation method for routine endoscopy. The proper propofol dosage based on individual patients and the presence of trained operators are crucial for NAAP sedation management.
引用
- Mandarino FV, Fanti L, Barchi A, et al. Safety and tolerability outcomes of nonanesthesiologist-administered propofol using target-controlled infusion in routine GI endoscopy. Gastrointest Endosc. 2023. PMID: 38128787. doi:10.1016/j.gie.2023.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。